139 related articles for article (PubMed ID: 8776545)
1. [Liberation of neopterin after lung resecting interventions with and without bronchial carcinoma].
Gebhard F; Lenz J; Brückner UB
Chirurg; 1996 Jul; 67(7):725-9. PubMed ID: 8776545
[TBL] [Abstract][Full Text] [Related]
2. Indices of immune activation after bronchial carcinoma surgery.
Sawa A; Kozioł-Montewka M; Goździuk K; Roliński J; Iłzecki M
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):161-6. PubMed ID: 15314978
[TBL] [Abstract][Full Text] [Related]
3. A study of interactions among markers of macrophage functions in metastatic solid tumors: neopterin levels in relation to those of tumor necrosis factor-alpha and of soluble interleukin-2 receptors.
Lissoni P; Brivio F; Fumagalli L; Galimberti C; Cataldo M; Marsili MT; Brivio O; Barni S; Tancini G; Angelini A
J Biol Regul Homeost Agents; 1994; 8(1):32-5. PubMed ID: 7976492
[TBL] [Abstract][Full Text] [Related]
4. [Neopterin and interleukin 2 soluble receptors as biochemical markers of cellular immune response to surgical trauma].
Delogu G; Reale G; Marchei GG; Rezaeieh RH; Casula MA; Reale C; Signore L; Martinelli V
Ann Ital Chir; 1992; 63(3):359-62; discussion 363. PubMed ID: 1444001
[TBL] [Abstract][Full Text] [Related]
5. [Immunomorphology of lymph nodes and prognosis in lung cancer].
Di Giorgio A; Sammartino P; Canavese A; Arnone P; Sibio S; Accarpio F; Al Mansour M
Minerva Chir; 2001 Apr; 56(2):153-9. PubMed ID: 11353348
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory markers in exhaled breath condensate following lung resection for bronchial carcinoma.
Jungraithmayr W; Frings C; Zissel G; Prasse A; Passlick B; Stoelben E
Respirology; 2008 Nov; 13(7):1022-7. PubMed ID: 18764914
[TBL] [Abstract][Full Text] [Related]
7. [Effect of postoperative empyema on survival after pulmonary resection for bronchial carcinoma. Study of 18 cases].
Mello Teggia P; Ritossa C; Smrekar E
Minerva Chir; 1983 Feb; 38(3):113-22. PubMed ID: 6302564
[No Abstract] [Full Text] [Related]
8. Effects of cholecystectomy (laparoscopic versus open) on PMN-elastase.
Schietroma M; Carlei F; Cappelli S; Pescosolido A; Lygidakis NJ; Amicucci G
Hepatogastroenterology; 2007 Mar; 54(74):342-5. PubMed ID: 17523270
[TBL] [Abstract][Full Text] [Related]
9. Lung resection for bronchogenic carcinoma after pneumonectomy: a safe and worthwhile procedure.
Terzi A; Lonardoni A; Scanagatta P; Pergher S; Bonadiman C; Calabrò F
Eur J Cardiothorac Surg; 2004 Mar; 25(3):456-9. PubMed ID: 15019678
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival after surgical resection for bronchogenic carcinoma.
Jones JC; Kern WH; Chapman ND; Meyer BW; Lindesmith GG
J Thorac Cardiovasc Surg; 1967 Sep; 54(3):383-93. PubMed ID: 6037603
[No Abstract] [Full Text] [Related]
11. Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis.
Nassonov EL; Samsonov MY; Tilz GP; Beketova TV; Semenkova EN; Baranov A; Wachter H; Fuchs D
J Rheumatol; 1997 Apr; 24(4):666-70. PubMed ID: 9101499
[TBL] [Abstract][Full Text] [Related]
12. Resection for bronchogenic carcinoma involving the carina: long-term results and effect of nodal status on outcome.
Mitchell JD; Mathisen DJ; Wright CD; Wain JC; Donahue DM; Allan JS; Moncure AC; Grillo HC
J Thorac Cardiovasc Surg; 2001 Mar; 121(3):465-71. PubMed ID: 11241081
[TBL] [Abstract][Full Text] [Related]
13. Neopterin as a prognostic indicator in patients with carcinoma of the uterine cervix.
Reibnegger GJ; Bichler AH; Dapunt O; Fuchs DN; Fuith LC; Hausen A; Hetzel HM; Lutz H; Werner ER; Wachter H
Cancer Res; 1986 Feb; 46(2):950-5. PubMed ID: 3940654
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of tumor necrosis factor therapy with neopterin.
Peters KM; Dommaschk J; Grundmann R; Schaadt M; Schicha H
Arzneimittelforschung; 1990 Apr; 40(4):508-10. PubMed ID: 2357253
[TBL] [Abstract][Full Text] [Related]
15. Thoracoscopic versus thoracotomy approaches to lobectomy: differential impairment of cellular immunity.
Whitson BA; D'Cunha J; Andrade RS; Kelly RF; Groth SS; Wu B; Miller JS; Kratzke RA; Maddaus MA
Ann Thorac Surg; 2008 Dec; 86(6):1735-44. PubMed ID: 19021967
[TBL] [Abstract][Full Text] [Related]
16. Pneumonectomy for bronchogenic carcinoma: analysis of factors predicting survival.
Ramnath N; Demmy TL; Antun A; Natarajan N; Nwogu CE; Loewen GM; Reid ME
Ann Thorac Surg; 2007 May; 83(5):1831-6. PubMed ID: 17462408
[TBL] [Abstract][Full Text] [Related]
17. Surface markers of blood lymphocytes in bronchial carcinoma.
Bodolay E; Szabó G; Juhász I; Komoróczy Z; Diczházy A
Acta Med Hung; 1984; 41(2-3):121-7. PubMed ID: 6611544
[TBL] [Abstract][Full Text] [Related]
18. Modulation of macrophage response to interleukin-2 immunotherapy by interleukin-3 in cancer patients.
Lissoni P; Rovelli F; Barni S; Ardizzoia A; Pittalis S; Tisi E; Perlangeli V; Tancini G
Biol Chem Hoppe Seyler; 1992 Dec; 373(12):1217-22. PubMed ID: 1292506
[TBL] [Abstract][Full Text] [Related]
19. [VATS (video-assisted thoracoscopic surgery): possibilities and limits of surgical therapy of malignant lung diseases].
Stoelben E; Wehrmann U; Ockert D; Saeger HD
Zentralbl Chir; 1998; 123(10):1129-33. PubMed ID: 9848249
[TBL] [Abstract][Full Text] [Related]
20. [Limited surgery for bronchogenic carcinoma].
Fujimura S
Kyobu Geka; 2001 Jul; 54(8 Suppl):707-14. PubMed ID: 11517536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
